System and method for radiotherapy planning
By reducing the reference dose value in the radiotherapy program and re-applying the optimization process, the problem of idle cost function in the prior art is solved, achieving a more optimized dose distribution and lower dose delivery of healthy tissues.
Patent Information
- Application Number
- CN202410577772.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-05-11
- Filing Date
- 2024-05-10
- Publication Date
- 2024-11-12
AI Technical Summary
The existing radiation therapy plan optimization method becomes idle when the dose is equal to or less than the reference dose, resulting in the treatment plan being unable to be further optimized and opportunities for improvement are missed.
By receiving the reference dose value, the optimization process seeks a cost function to minimize the dose overvalue and reduces the reference dose value when the dose overvalue is below the threshold, reapplying the optimization process to continue optimizing the treatment plan.
Preventing the cost function from becoming idle allows further optimization of treatment plans, reduce dose delivery to healthy tissues, and provide a more optimized treatment regimen.
Smart Images

Figure CN118925085A_ABST
Abstract
Description
Technical Field
[0001] Embodiments of the present invention relate to systems and methods for implementing a treatment plan for radiation therapy. More specifically, embodiments of the present invention relate to a computer-implemented method for radiation therapy planning, and a data processing device, a computer program, and a non-transitory computer-readable storage medium configured to perform the method for radiation therapy planning. Background Art
[0002] Radiation therapy, or radiotherapy, is the use of ionizing radiation (such as X-rays or charged particles) to damage or destroy unhealthy cells in the human or animal body. During treatment, the ionizing radiation is formed into a beam and directed to unhealthy cells in the body, such as a tumor. The cells to be treated may be deep inside the body or close to the surface, such as in the skin.
[0003] The delivered dose distribution depends on treatment parameters such as beam direction, dose per beam, number of beams, beamlet weights, and exposure time. Radiation therapy planning is the process of determining a set of treatment parameter values that will provide the desired treatment with minimal damage to surrounding healthy tissue. Treatment planning can be done using e.g. treatment planning system to execute.
[0004] While the "ideal" dose distribution is to deliver at least the minimum required dose to unhealthy cells and zero dose to healthy cells, in reality some dose delivery to surrounding healthy tissue is unavoidable. Therefore, the purpose of the treatment plan is to optimize the delivered dose distribution so that unhealthy cells receive at least the minimum required dose and healthy cells receive as little dose as possible, especially any sensitive or compromised anatomical parts. An optimization process is performed to determine the optimal set of parameters that will deliver the appropriate dose. The optimization process can be subject to clinical and dosimetry goals and constraints. For example, goals and constraints can specify maximum, minimum and / or average radiation doses for different regions of the body. Constraints are conditions that must be met, such as a minimum dose to an area including a tumor. These goals are goals to be achieved. For example, a goal can be that the dose delivered to a specific area including healthy tissue does not exceed the maximum radiation dose, also known as a reference dose. Goals and constraints can also involve any other treatment parameters, such as beamlet weights, the number of radiation beamlets, the range of movement of the radiotherapy device, etc.
[0005] During treatment planning, anatomical regions of the patient are modeled using three-dimensional images of the patient, such as computed tomography (CT) images. Image segmentation is performed to define different regions within the image, called segments. Different objectives and constraints can be defined for different segments. The characteristics used to characterize the segments can include, for example, any characteristics that affect dose requirements, such as tissue type, cell health, sensitivity to radiation, anatomical structure, and organ function. The area identified as requiring treatment (e.g., an area including a tumor) is called the clinical target volume (CTV). The area to which treatment is to be implemented is called the planning target volume (PTV), and is typically the CTV plus a margin that is added to help ensure that the CTV is effectively treated. Areas where treatment doses are not expected are called organs at risk (OARs).
[0006] The goal of the optimization problem is to determine a radiation therapy plan that satisfies the constraints and objectives as closely as possible.
[0007] Treatment planning is a time consuming and complex process. Therefore, there is a need for improved methods and systems for generating treatment plans. Summary of the invention
[0008] The treatment plan can be optimized by minimizing a cost function that provides a measure of the extent to which the dose distribution achieved by the treatment plan meets the objectives. For example, a dose excess cost function provides a measure of the difference between the dose achieved by the treatment plan (e.g., the dose in an anatomical region) and a reference dose (e.g., the maximum acceptable dose in that region). The cost function is calculated for a specific region of the body, such as a region including a PTV or an OAR. The optimization process seeks to minimize the cost function by adjusting the treatment plan subject to relevant objectives and / or constraints.
[0009] However, this optimization method may be problematic. When the dose achieved by the treatment plan is equal to or less than the reference dose, the cost function is zero. At this point, the cost function cannot be further reduced by optimization, so the cost function becomes idle. However, in many cases, the cost function becomes idle before the treatment plan is fully optimized. In other words, although the dose delivered to the OAR is equal to or less than the reference dose, the dose can still be reduced by further adjusting the treatment plan. In these cases, the opportunity to further improve the treatment plan may be missed.
[0010] Embodiments of the present invention seek to address this problem by providing a computer-implemented method for radiotherapy treatment planning, wherein the reference dose value is reduced when the optimization process provides a treatment plan (or dose distribution) with a dose excess value below a threshold. Thus, the method prevents the cost function from becoming idle and enables the treatment plan to be further optimized.
[0011] According to a first aspect, a computer-implemented method for radiotherapy treatment planning is provided. The method includes receiving a reference dose value, wherein the reference dose value is a maximum radiation dose defined within a first region in a patient for radiotherapy. The method also includes applying an optimization process to a treatment plan for radiotherapy of the patient. The optimization process seeks to minimize a cost function representing a dose excess value above the reference dose value. The method also includes, in response to determining that the dose excess value is below a threshold: reducing the reference dose value; and reapplying the optimization process to the treatment plan. The optimization process seeks to minimize the cost function based on the reduced reference dose value.
[0012] According to a second aspect, a data processing apparatus is provided, comprising a memory storing computer executable instructions and a processor. The processor (or controller circuit) is configured to execute the instructions to perform the method of the first aspect.
[0013] According to a third aspect, there is provided a computer program comprising instructions which, when the program is executed by a computer, cause the computer to perform the method of the first aspect.
[0014] According to a fourth aspect, there is provided a non-transitory computer-readable storage medium comprising instructions which, when executed by a computer, cause the computer to perform the method of the first aspect.
[0015] Thus, the present invention provides an improved method for radiation therapy planning. The disclosed method provides a treatment plan that delivers a reduced dose to OARs compared to existing methods. These benefits are achieved in an automatic manner that does not require user interaction. Advantageously, the technology can be applied to a wide variety of patients and anatomical structures, and allows for the determination of an improved treatment plan for each individual patient.
[0016] Embodiments of the invention may be implemented in digital electronic circuitry, or in computer hardware, firmware, software, or a combination thereof. Embodiments of the invention may be implemented as a computer program or computer program product, i.e., a computer program tangibly embodied in a non-transitory information carrier (e.g., in a machine-readable storage device or in a propagated signal) so as to be executed by one or more hardware modules or to control the operation of one or more hardware modules. The computer program may be in the form of a stand-alone program, a computer program portion, or more than one computer program, and may be written in any form of programming language (including compiled or interpreted languages), and it may be deployed in any form, including as a stand-alone program or as a module, component, subroutine, or other unit suitable for use in a data processing environment.
[0017] The present invention is described herein according to specific embodiments. Other embodiments not explicitly described herein may still fall within the scope of the claims. Unless otherwise specified explicitly or implicitly, the steps of the method according to an embodiment of the present invention may be performed in different orders and still achieve the desired result. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Exemplary embodiments will now be described, by way of example only, with reference to the accompanying drawings, in which:
[0019] Figure 1A is a block diagram illustrating an optimization process according to various embodiments of the present invention;
[0020] Figure 1B is a block diagram illustrating a two-stage optimization process according to various embodiments of the present invention;
[0021] Figure 2 is a flowchart illustrating a computer-implemented method according to various embodiments of the present invention;
[0022] Figure 3 is a schematic diagram of a computing device according to various embodiments of the present invention;
[0023] Figure 4 is a schematic diagram of a computer-readable medium according to various embodiments of the present invention; and
[0024] Figure 5 is a schematic diagram of a radiation therapy device. DETAILED DESCRIPTION
[0025] Figure 1A 1 is a block diagram illustrating an optimization process 100 for determining a parameter set (ie, one or more parameters) that defines a radiation therapy plan for a radiation therapy system. Figure 5 Examples of radiation therapy systems are described.
[0026] The optimization module 100 includes an optimizer 107, which is configured to receive at least: a model 101, a cost function 102, and one or more parameters 103. Optionally, the optimizer 107 may also receive constraints 105 and / or a reference target 104. The optimization module 100 performs an optimization process and outputs a set of optimization parameters 111 that minimize the cost function 102. The optimization parameters 111 are the values of the one or more parameters 103 input to the optimizer 107. The optimization module 100 may also output one or both of a cost function value 109 (the cost function 102 evaluated using the optimization parameters 111) and an achieved target value 113 (for comparison with the reference target 104).
[0027] The optimizer 107 uses at least one optimization algorithm, such as a simplex algorithm, a gradient-based algorithm, an interior point algorithm, etc., or a combination thereof. Those skilled in the art will appreciate that other optimization algorithms are possible, and the present invention is not limited to any particular optimization algorithm. The optimization process may correspond to the optimization process described in European patent application publication EP3681600A1, for example.
[0028] The model 101 is a representation of the anatomical region to be treated. For radiation therapy planning, the anatomical region may include one or more anatomical regions (i.e., sub-regions), such as one or more of the following regions: a target region, a healthy tissue region (OAR), a planning target volume, a critical structure, or a shell structure. These regions or structures may be determined or defined by performing image segmentation of a three-dimensional image or model of the anatomical region. Shell structures are structures generated to adjust the dose delivered to tissue surrounding the target, and they may be used to control dose conformality.
[0029] The cost function 102 is a mathematical formula that provides a measure of the extent to which the parameter set 103 satisfies a reference target 104 (e.g., one or more targets). The cost function 102 evaluates a dose distribution over a region of the model 101 based on the parameter set 103. The region may be divided into voxels, and a dose is calculated per voxel. The dose distribution may be calculated using a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. The dose distribution reference Figure 1B A more detailed description and additional details on how the dosage may be determined are given in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.
[0030] The cost function 102 relates the dose distribution to a single value, referred to as the cost function value 109. The cost function 102 may define a penalty for violating one or more objectives. A cost function may also be referred to as an objective function.
[0031] The optimizer 107 evaluates the cost function 102 during the optimization. The optimizer 107 changes the optimizable parameters 103 so as to minimize the cost function 102. Optionally, in constrained optimization, the constraint 105 does not contribute to the cost function, but violating the constraint 105 results in the rejection of the treatment plan. For example, the reference target can be an average dose to a healthy organ (e.g., bladder) that is less than a dose value (e.g., 30 Gy), and the constraint can be a maximum dose to the patient (as a whole) that is less than another dose (e.g., 50 Gy). The cost function can provide a mathematical formula for calculating the average dose to the bladder, and the optimizer aims to obtain a reference target that obeys the constraint (a dose to the bladder that is less than 30 Gy). The optimized solution provided by the optimizer can include a dose to the bladder that is less than or greater than 30 Gy, but if the optimizer cannot find a solution with a maximum dose to the patient that is less than 50 Gy, no solution will be provided (e.g., no treatment plan). Constraints can be referred to as special types of cost functions that cannot be violated in some cases (so the value of the cost function is unimportant), however, such terms are not used in this article.
[0032] One or more parameters 103 are optimizable parameters (also referred to as decision variables or treatment parameters) for which the optimizer 107 attempts to find optimal values. The optimizable parameters 103 may relate to characteristics of the radiation to be delivered by the radiotherapy system. For example, the optimizable parameters 103 may include one or more of the following parameters: beamlet weights, beam angles, dose histogram volume information, the number of radiation beams, the dose per beam, and a dose excess value (e.g., a root mean square dose excess value above a reference dose). One or more parameters 103 may be initialized to a predetermined set of values, such as a "best guess" set of values or an arbitrary set of values. Alternatively, the parameters 103 may be initialized to values determined in a previous step. For example, when performing multiple optimizations, the parameters may be initialized to values determined in a previous optimization process (e.g., based on different reference targets 104).
[0033] Constraints 105 include one or more conditions that the optimization parameters 111 must satisfy. Constraints 105 may include one or more hard constraints (conditions that the parameters 111 are required to satisfy). Constraints limit the set of possible solutions and can be used to define what is physically possible and / or clinically acceptable. Note that constraints 105 are optional features.
[0034] Reference targets 104 include targets that the optimizer is attempting to achieve. For example, reference targets may relate to dose-based targets and / or volume-based targets. Dose-based targets may include dose values (in Gy), such as a maximum, minimum, or average dose for a given region of the model 101. Volume-based targets may include relative volumes (e.g., fractions / percentages of the volume of a region of the model 101) or absolute volumes. Absolute volumes may be based on physical dimensions (e.g., in mm, cm, mm 3 、cm 3 For example, the reference target 104 may require that at least X% of the first region receive at least YGy during treatment.
[0035] Additionally, the reference target 104 may include an indication of the cost function 102 to be used. The reference target 104 may also include an indication of the anatomical structure for which the target to be achieved applies, such as the region of the model 101 for which the maximum / minimum / average dose applies. The optimizer 107 will determine a set of optimized parameters 111 that results in an achieved target value 113 close to the reference target 104. Note that the reference target 104 is an optional feature.
[0036] Thus, reference target 104 is an anatomical structure specific function that establishes a dose and / or biological response target, and constraint 105 is an anatomical structure specific function that can be hard or soft. When constraints are used with targets, constraints are hard constraints that must be satisfied. In contrast, targets are goals that optimizer 107 attempts to achieve.
[0037] The cost function 102, together with the model 101, parameters 103, constraints 105 (optional), and reference goals 104 (optional), defines the problem to be solved. The term "treatment planning goal" can collectively refer to all aspects of the reference goal 104 and / or constraints 105. For example, each of the rows m to x in Table 1 below represents a treatment planning goal and states: the type of constraint; the hierarchical order; the relevant structure of the model to which the constraint is applied; the cost function to be used; and the goal to be achieved.
[0038] As described above, the optimizer 107 aims to find an optimized set of parameters 111 for which the cost function 102 is minimized. The optimized parameters 111 are the output of the optimizer 107. In one example, when there is a reference target 104, the optimizer 107 minimizes the difference between the target value 113 and the reference target 104.
[0039] Optionally, the optimizer 107 outputs a cost function value 109. The cost function value 109 is the value of the cost function 102 when evaluated using the optimization parameters 111.
[0040] Optionally, the optimizer 107 outputs an achieved target value 113. The achieved target value 113 typically has the same units as the reference target so that it can be compared with the reference target 104. The achieved value 113 may be different from the cost function value 109. Unlike the cost function value 109, which may be a number that is an evaluation of a cost function, the achieved value 113 may have a physical meaning. In one example, when the reference target 104 includes a dosimetry target in units of gray (Gy), the achieved target value 113 also relates to the dose (i.e., it has the unit Gy and / or the same physical meaning as the reference target 104). In another example, when the reference target 104 includes a reference volume and a dose value, the achieved target value also relates to the reference volume and the dose value (i.e., it has the same physical meaning as the reference target). As will be described below with respect to Table 1, the reference target 104 may be based on a dose volume histogram (DVH) and may be a target for a percentage of a volume that receives a predetermined dose. The achieved target value 113 will be the achieved percentage of the volume that receives the predetermined dose. In other words, the achieved target value 113 may be compared to the reference target 104 .
[0041] The optimization process 100 can be repeated for one or more different reference targets 104. In other words, the treatment plan can be divided into a series of optimization problems, wherein each optimization problem focuses on a specific target (i.e., the reference target 104) and optionally obeys one or more constraints. Different reference targets 104 can, for example, involve different (or overlapping) anatomical regions (or shells or structures) in the patient's body. The output of the first optimization process 100 can contribute to the second optimization process 100. For example, the reference target 104 of the previous optimization process can be set as a constraint 105 for a subsequent optimization process. In this case, the reference target 104 can have a corresponding priority, so that the order of solving the optimization problem can be determined based on its corresponding priority. Therefore, the optimization process 100 can be performed first for the reference target 104 with the highest priority, and the subsequent optimization process can be performed in the order of decreasing priority. If the reference target 104 cannot be met, the reference target 104 can be revised, and the optimization is repeated using the revised reference target 104.
[0042] As an example, Figure 1A The optimization process 100 illustrated in FIG. 1 can be applied to intensity modulated radiation therapy (IMRT). In IMRT, one or more radiation beams are directed to a tumor, and the intensity of each beam profile is non-uniform. In this example, the execution Figure 1AAn optimization process 100 is provided to determine the weights of the radiation beamlets (the weights corresponding to the parameters 103). The cost function 102 includes a mathematical expression that relates the dose distribution at a unit integral flux to the beamlet weights 103. The cost function 102 incorporates a reference target 104, which sets forth the maximum dose (i.e., the reference dose) of the first region of the model 101 including the OAR. If the dose in the first region exceeds the maximum dose, a penalty is induced in the cost function 102 (i.e., the value of the cost function 102 increases). The cost function 102 further incorporates a hard constraint 105 that the beamlet weights cannot be negative (because negative beamlet weights are impossible). The output of the optimization process 100 includes optimized beamlet weights 111.
[0043] Although the above examples apply to IMRT, note that the optimization process 100 may be applied to other radiation therapy modalities.
[0044] The optimization process 100 can be part of the first stage of the treatment planning process, in which the radiation flux map (or intensity map) is optimized. The flux map indicates the expected radiation dose across the region according to the radiation treatment plan. The first stage can include, for example, one or more optimization processes 100 corresponding to one or more reference targets 104.
[0045] The first stage may be followed by a second stage, wherein the optimized parameters 111 from the first stage are used to determine the configuration of the treatment planning system for the treatment to be performed. Both the first and second stages will refer to Figure 1B Describe in more detail.
[0046] It will be understood that the technology disclosed herein is not limited to reference Figure 1B A two-stage approach is described.
[0047] Figure 1B is a block diagram illustrating a two-stage optimization process 150. The process 150 is described herein with reference to IMRT treatment planning, but it can also be applied to volumetric modulated radiation therapy (VMAT). Furthermore, it is noted that the optimization process 150 can also be applied to other radiation therapy modalities.
[0048] The purpose of the optimization process 150 is to modify the IMRT beam intensity profile so that a sufficiently high dose is delivered to the tumor while reducing the dose delivered to healthy organs.
[0049] The optimization method of IMRT 150 includes two stages. The first stage (step 151) is the flux map optimization (FMO), and the second stage (step 153) is to determine the configuration of the radiation therapy system. In FMO 151, the optimal flux map is determined. Then, the optimal flux map is used to determine the configuration of the radiation therapy system in step 153.
[0050] For fluence optimization 151, each beam is divided into a plurality of beamlets. Then, the contribution of each beamlet to the voxel at unit fluence is calculated. During optimization, the weights of each beamlet are adjusted so that the cost function is minimized. By multiplying the weight by the contribution of each beamlet at unit fluence, a full dose distribution can be obtained. The full dose distribution can be compared with any constraints and / or reference targets to determine whether the optimized solution is suitable.
[0051] The optimization process of FMO can be referred to Figure 1A The optimization process 100 described herein is performed and will be further described below.
[0052] Optimization 151 includes minimizing a cost function f(x) by determining appropriate values of parameters x based on certain constraints g. For FMO, parameters x may correspond to weights of beamlets (parameters x may also be referred to as decision variables). The output of FMO (step 151) includes the optimized values of parameters x.
[0053] The constraints g include limits. Examples of limits are a minimum dose at a voxel corresponding to a target, or a maximum dose at a voxel corresponding to an OAR, and so on.
[0054] In one example, the cost function f(x) is:
[0055] f(x) = T1 + T2 + ... + T3, (Equation 1)
[0056] Where, for example, T1 = ∑x n ·d n , where x corresponds to the weight of the beamlet, d n represents the dose of each beamlet to a voxel at a unit intensity. The voxel is obtained from the above model 101, so d n Associated with Model 101. d n is a non-optimizable parameter (e.g., it may depend on the machine configuration and / or characteristics of the tissue). In one example, the dose d n It can be determined by a pencil beam algorithm, a convolution-based algorithm and / or a Monte Carlo (MC)-based algorithm. Optionally, the dose calculation uses a pencil beam algorithm or a convolution-based algorithm, which is faster than an MC-based algorithm but has reduced accuracy, i.e., results in a less realistic dose calculation. How the dose d can be determined n Additional details are in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.
[0057] The output of stage 1 (step 151) may include a dose distribution.
[0058] In this example, the objective function f(x) is the sum of the total doses (T1, T2 ... T3), where each of T1, T2 ... T3 represents the dose on a different structure. Note that alternative formulations of the problem to be solved may be used (e.g., by defining different cost functions or constraints).
[0059] In one example, a requirement for the dose at the target to be above a certain amount can be formulated as a constraint. Alternatively, such a requirement can be formulated as a reference target.
[0060] Step 151 provides an optimized set of parameters (eg beamlet weights x) that will provide an optimal intensity map (or flux map).
[0061] In preparation for delivery by a radiotherapy system, a further step (step 153) is required to convert the individual optimized beamlet weights into a configuration of the machine that will deliver the optimal fluence.
[0062] At step 153, the output from step 151 is converted into a configuration of a radiation therapy system. The configuration may be used by a radiation therapy device (examples of which are described herein) to deliver radiation therapy. For example, the configuration of a radiation therapy system includes a set of aperture configurations (i.e., one or more aperture configurations). The shapes and weights of the aperture configurations are selected to meet the same goals as in the first stage. The aperture configurations may be configured by a beam shaping device (e.g., Figure 5 Part 550) is implemented.
[0063] The aperture configuration may be referred to as a control point or segment. The control point and / or segment includes radiation information (e.g., energy, dose) and geometric information (e.g., gantry angle and leaf position). The shape and weight of the aperture may be determined by applying algebraic and trigonometric considerations to the arrangement of the aperture in order to achieve the optimized beamlet weights of step 151.
[0064] Alternatively, step 153 includes performing a second stage optimization process to determine an optimized aperture configuration that will achieve the optimized fluence pattern determined in step 151. The second stage optimization process may be referred to as aperture optimization or aperture refinement.
[0065] Aperture optimization can include the following:
[0066] - Receive a set of beamlet weights (eg, from step 151).
[0067] - Perform an optimization to determine the optimized aperture shape and optionally weights. The optimization can be performed using e.g. Figure 1A Other optimization procedures are also possible.
[0068] When the beam shaping device includes a multi-leaf collimator (MLC), aperture optimization may include:
[0069] - Receiving a set of beamlet weights from a FMO and / or a flux profile (eg from step 151 ).
[0070] - Convert the received profile into beamlet widths (openings between leaf pairs). This produces segments.
[0071] - Optimize the weights of the resulting segments.
[0072] - Optionally, optimizing the shapes of the generated segments (using a process known as segment shape optimization).
[0073] Note that the optimization step in step 153 may include calculation of a dose distribution. The dose distribution may be calculated using a pencil beam algorithm, a convolution-based algorithm, and / or a Monte Carlo (MC)-based algorithm. Optionally, the dose calculation in step 153 uses an MC-based algorithm (which is more accurate but computationally expensive).
[0074] Additional details on aperture optimization are given in The training guide (Document ID: LTGMON0530 (Elekta AB)) is provided.
[0075] The step of determining the configuration of the radiation therapy system (step 153) is based on at least the set of optimized parameters from stage one (step 151).
[0076] Although Figure 1B The example of involves a two-stage optimization process for IMRT (FMO at step 151 and configuration determination at step 153), but note that alternative optimization methods such as direct machine parameter optimization (DMPO) may be used instead. In DMPO, the decision variables x correspond to parameters of the machine that delivers the radiation (e.g., MLC leaf positions).
[0077] Returning to the cost function 102 in the optimization process 100, examples of cost functions include: target EUD, target penalty, secondary overdose, secondary underdose, continuous, parallel, maximum dose, overdose DVH, underdose DVH. These cost functions are briefly described below. Each cost function provides a different calculation method.
[0078] When the cost function includes any of target penalty, parallelism, overdose DVH, and underdose DVH, the reference target 104 is a dose value and a relative volume component (eg, percentage) or an absolute volume (eg, in cc).
[0079] When the cost function includes any of target EUD, secondary overdose, continuous, maximum dose, or conformality, the reference target 104 is a dose value.
[0080] Cost functions such as continuous, parallel, secondary overdose, overdose DVH, or maximum dose are intended to limit the dose at the anatomical structure. Cost functions such as secondary underdose or underdose DVH are intended to increase the dose at the anatomical structure. Cost functions such as target EUD and target penalty are intended to increase the dose at the structure. Some of the above cost functions also take unitless numbers as input. The unitless number (k) is a power law exponent.
[0081] The target EUD cost function defines the structure as the target volume and expresses the probability of target cells surviving at a given dose. The cost function requires a specified dose as input (i.e., the reference target of the cost function is the dose value). The specified dose in Gy is the equivalent uniform dose (EUD). EUD is a uniform dose that, if delivered at the anatomical structure, has the same clinical effect as a non-uniform dose distribution.
[0082] The target penalty cost function takes as input a prescribed dose and a minimum volume (i.e., the reference targets of the cost function are dose and relative volume). The target penalty is a quadratic penalty that starts with a threshold dose. It produces a steeper dose gradient after the target threshold is met. The target penalty is used to define the requirement that at least some portion of the total anatomical volume should receive at least the target dose.
[0083] The quadratic dose excess (QO) cost function is a cost function used to limit the dose in the structure to which the dose is applied. QO can be applied to the target or OAR. The QO cost function can be used to limit hot spots in the target. The QO cost function takes the maximum dose and the maximum root mean square (RMS) dose excess as input. The maximum dose defines the dose above which a penalty occurs in the cost function. The maximum RMS dose excess defines an acceptable violation. The maximum dose and / or the maximum RMS dose excess can be defined by the user.
[0084] The quadratic underdose cost function is a cost function applied to the target volume. The quadratic underdose function implements a quadratic penalty. The cost function takes as input a minimum dose in Gy and a maximum dose deficit in Gy (i.e., the reference target includes two dose values). The minimum dose is the minimum dose allowable in the target and represents the dose below which the penalty occurs. The maximum dose deficit is similar to the maximum RMS dose excess in that it defines the amount of acceptable prescription violation.
[0085] The continuous cost function is often used with continuous OARs. Continuous anatomical structures are structures where high doses are harmful even if they are confined to a small volume. Examples include the spinal cord and intestine. This cost function imposes a large penalty on hot spots even if they are small in volume. The cost function takes as input the EUD in Gy and a power law exponent k (i.e., the reference target includes both the dose value and the unitless number).
[0086] Parallel cost functions are often used for parallel OARs. Parallel structures are structures that tolerate very high doses in a small volume while the rest of the organ is protected. Examples are lung, parotid, kidney, liver. The cost function takes as input a reference dose in Gy, an average organ damage (which is the fraction of the volume of the structure that can be sacrificed), and a power law exponent k (i.e., a reference target includes a dose value, a relative volume, and a unitless number).
[0087] The maximum dose cost function is effectively a hard barrier that can be applied to target structures or OARs. The maximum dose cost function has a penalty that takes effect whenever a voxel crosses a maximum dose threshold. The cost function takes as input the maximum dose in Gy (ie, the reference target includes the dose value).
[0088] The overdose DVH cost function takes as input a target dose in Gy and a maximum volume (i.e., a reference target includes a dose value and a relative volume). This cost function is applied to OARs. The goal is to keep the volume that receives more than the target dose below the relative volume.
[0089] The underdose DVH cost function takes as input a target dose in Gy and a minimum volume (i.e., a reference target includes a dose value and a relative volume). The cost function is applied to the target. The goal is to keep the target volume that receives less than the target dose above the minimum volume.
[0090] Additional details of the cost function are given in Training Guide (provided in document ID: LTGMON0530 (Elekta AB)).
[0091] Figure 2 The flowchart in exemplifies a computer-implemented method 200 for radiation therapy planning according to various embodiments of the present invention.
[0092] A radiation therapy plan can be used for radiation therapy using any type of ionizing radiation, such as X-rays, electrons, protons, or ions. The radiation therapy can be, for example, IMRT, VMAT, image-guided radiation therapy (IGRT), proton beam therapy (PBT), intensity modulated proton therapy (IMPT), or electron beam therapy (EBT). The treatment plan can be used to treat any part of the human or animal body.
[0093] Method 200 includes, in step 201, receiving a reference dose value. The reference dose value is a maximum radiation dose defined in a first region of a patient for radiation therapy. Thus, the reference dose value may represent a reference target for an optimization process, for example, the reference dose value may correspond to a value for Figure 1AThe reference target 104 described above can be a target to be achieved by an optimization process for determining a treatment plan in which a dose delivered to the first region does not exceed a reference dose value. For example, a reference dose value can be received as input by a clinician or user in step 201. For example, a clinician can select a reference dose value based on a tissue type in the first region. The clinician or user can communicate the reference dose value to an execution Figure 2 The method 200 is a data processing apparatus.
[0094] The first region may be an anatomical region of the patient, for example, the first region may include one or more of the following regions: a target region for radiotherapy, a healthy tissue region (OAR), a PTV, a critical structure, and a shell structure. The first region may be a sub-region of a larger anatomical region to receive treatment. The first region may be defined by image segmentation (e.g., by performing image segmentation of a two-dimensional or three-dimensional image or model of the larger anatomical region). In some embodiments, receiving a reference dose value also includes receiving an indication of the first region.
[0095] The method 200 also includes, at step 202, applying an optimization process to a treatment plan (e.g., a dose distribution or flux map) for radiation treatment of the patient. The optimization process seeks to minimize a cost function representing a dose excess above a reference dose value. For example, the optimization process may correspond to a reference dose value. Figure 1A The optimization process 100 described herein can iteratively adjust the treatment plan to minimize the cost function. In this document, the term treatment plan can refer to a dose distribution or flux map for an anatomical region including the first region. The dose excess value can be an optimizable parameter for the optimization process, for example, it can correspond to a reference Figure 1A Parameter 103 described herein (or included therein). In some embodiments, the dose excess value is a root mean square dose excess value.
[0096] The cost function may be a secondary overdose cost function. For example, the cost function may be proportional to:
[0097]
[0098] It represents the sum over the i voxels in the volume V of the first region, where V i is the volume of the ith voxel, D i is the dose delivered to the ith voxel, Δ is the reference dose value, and the operator [D i -Δ] + Indicates [D i -Δ] and the maximum value among zero.
[0099] The optimization process may seek to minimize the cost function with respect to one or more optimizable parameters. As described above, the dose excess value may be an optimizable parameter of the optimization process. The one or more optimizable parameters may also include, for example, one or more of the following parameters: beamlet weights, beam angles, dose histogram volume information, the number of radiation beams, and the dose per beam.
[0100] The received reference dose value may be a reference target for the optimization process, for example, it may correspond to Figure 1A Reference target 104 is described.
[0101] Reference targets for the optimization process may include a reference dose value and a maximum dose excess value, such as a maximum RMS dose excess value. The maximum dose excess value is an indication of a maximum violation of the reference dose value (e.g., the amount by which the dose achieved by the treatment plan may exceed the reference dose value). For example, the maximum RMS dose excess value may indicate a maximum value of a cost function. The maximum dose excess value represents a target for the optimization, such as a target to be achieved.
[0102] The method 200 may also include receiving a maximum dose excess value prior to applying the optimization process. For example, the maximum dose excess value may be determined by a user or a clinician.
[0103] The reference objective of the optimization process may also include one or more of the following objectives: an indication of the first region; an indication of the cost function; a cost function value; and a priority of the reference objective.
[0104] In some embodiments, the optimization process also seeks to minimize a cost function subject to one or more constraints. For example, one or more constraints may relate to a first region and / or one or more different (e.g., adjacent or overlapping) anatomical regions. One or more constraints may, for example, relate to a target or OAR of radiation. One or more constraints may also or alternatively relate to one or more different cost functions, such as secondary dose overdose, continuity, parallelism, etc. One or more constraints may include constraints that were the objectives of a previous optimization process and have now been fixed as constraints. For example, when a treatment plan is generated, multiple optimization processes may be performed sequentially. The treatment plan may first be optimized with respect to a higher priority goal; once optimized with respect to a higher priority goal, the treatment plan is optimized with respect to a lower priority goal, and the higher priority goal is set as a constraint. In this way, the treatment plan preferentially achieves the higher priority goal; once the higher priority goal has been solved, the lower priority goal is solved, and the degree to which the achievement of the higher priority goal is allowed is reached.
[0105] The optimization process may output an optimized parameter set for the treatment plan (e.g., the optimized parameter set may correspond to Figure 1AThe optimized parameters 111 described above can be used to optimize the radiation dose in the first region. For example, the optimized parameters can define a flux map for treatment. The optimization process can also output one or more of the following: a cost function value; an achieved radiation dose in the first region; and a dose excess value (e.g., an RMS dose excess value).
[0106] In step 203, the method 200 further includes, in response to determining that the dose excess value is below the threshold: reducing the reference dose value, and reapplying the optimization process to the treatment plan. The optimization process (when reapplied) seeks to minimize the cost function based on the reduced reference dose value. For example, the reduced reference dose value may correspond to the updated reference target 104.
[0107] Reducing the reference dose value prevents the cost function from becoming idle (i.e., no longer contributing to optimization). For example, when the dose excess value is approximately in the range of 0.1 to 1.0 Gy, the cost function can perform well, but when the dose excess value (and therefore the cost function) is reduced to zero (or close to zero) (e.g., less than 0.1 Gy), the cost function becomes idle. This occurs when the dose delivered to each voxel is less than the reference dose value. Reducing the reference dose value according to the present invention results in an increase in the cost function. Therefore, the cost function is prevented from becoming idle before the dose to be delivered to the first area is fully optimized (i.e., reduced as much as possible within the constraints of the optimization problem). Using the reduced reference dose value, the undesired dose within the treatment plan can be further reduced. Therefore, reducing the reference dose value according to the present invention provides an improved treatment plan.
[0108] The threshold is equal to or less than the maximum dose overdose value. In some embodiments, the threshold is used to determine whether to reduce the reference dose value only when the maximum dose overdose value is met (ie, the achieved dose overdose is less than the maximum dose overdose value).
[0109] The threshold value may be received (eg as user input) by a data processing device executing method 200. Alternatively, the threshold value may be stored in a memory included in or accessible by the data processing device. Thus, method 200 may further include receiving the threshold value before applying the optimization process.
[0110] Method 200 may also include, in step 204, iteratively reducing the reference dose value and reapplying the optimization process until the stop criterion is reached. For each iteration, the reference dose value may be reduced by a fixed value. For example, the fixed value may be between 0.3Gy and 0.7Gy (e.g., 0.5Gy), but other values may also be suitable depending on factors such as the treatment type and the first region. Alternatively, the reference dose value may be reduced by an amount based on one or more of the following: a reference dose value, a threshold, and the difference between the reference dose value and the threshold. For example, the reference dose value of the (i+1)th iteration may be reduced by a percentage of the reference dose of the i-th iteration, such as 5% of the reference dose or any other percentage value. In some embodiments, the percentage value may be between 2% and 15%, including end values.
[0111] The computer implemented method 200 thus converges to a better treatment plan than would otherwise be obtained. This is achieved without requiring user input, thus providing an automatic, reliable and time efficient method for treatment planning.
[0112] The stopping criterion may include that the optimization process cannot reduce the cost function such that the dose excess value is below a threshold. The stopping criterion may include that the optimization process cannot reduce the cost function such that the dose excess value is below a threshold after a defined number of optimization iterations or a defined amount of time. Alternatively, the stopping criterion may simply be a defined number of optimization iterations or a defined amount of time.
[0113] Method 200 may also include step 205: in response to determining that the stop criterion has been reached, outputting an optimized parameter set for the treatment plan. For example, the optimized parameters may be output for review by a user. Alternatively, the optimized parameters may form a set of parameters for use in a subsequent optimization process (e.g., corresponding to Figure 2 Method 200 and / or Figure 1A The input parameters of the process 100 (e.g. corresponding to Figure 1A Parameter 103).
[0114] In some embodiments, method 200 further includes, at step 206, determining a configuration of the radiation therapy system for treatment planning based on the optimized parameter set. For example, this step may correspond to Figure 1B Step 153.
[0115] As mentioned above, Figure 2 The output of method 200 can be input into a subsequent optimization process. For example, the optimization parameter set obtained by method 200 can be an input parameter of a subsequent optimization process (e.g. Figure 1A Parameters 103). Similarly, method 200 can use the output parameters of the previous optimization process as input parameters. The use of multiple optimization processes in treatment planning is further explained with reference to Table 1 below.
[0116] Table 1: Example of a wish list
[0117]
[0118]
[0119] Table 1 is an example of a portion of a clinical prescription for a radiation therapy plan for the treatment of prostate cancer, also referred to as a wish list. The wish list defines what the treatment plan is expected to achieve and can be defined by the user. The wish list includes one or more constraints (rows 1 to 1 of Table 1) and / or one or more goals (rows m to x of Table 1). Here, each goal (i.e., each of rows m to x) corresponds to a constraint with respect to the treatment plan. Figure 1A 104. Alternatively (not shown in Table 1), any of the objectives of Table 1 may be formulated as constraints instead. The constraints (i.e., each of rows a to l) correspond to Figure 1A Description of constraints 105.
[0120] The wish list shown in Table 1 includes "clinical" constraints (rows a to f). The wish list also includes "planning" constraints (rows g to l). The purpose of the "planning" constraints is to achieve dose conformality and control potential hot spots.
[0121] Clinical constraints and planning constraints are predefined constraints. These constraints cannot be violated, so violating any of these constraints leads to plan rejection. The purpose of the constraints in rows a to l is to limit the dose at the corresponding structure.
[0122] The wish list also includes prioritized goals (rows m to x). The priority of each goal is given in the second column. The prioritized goals correspond to Figure 1A Reference goals for description. Prioritized goals include: goals related to dose coverage and conformality of the target (which are 1st priority goals in rows m to q) and goals related to dose protection of OARs (rows r to y).
[0123] Priority refers to the relative priority of the referenced objectives. In Table 1, the objectives related to dose coverage and conformality of the target are optimized first (which are the 1st priority objectives in rows m to q), and then the objectives related to dose protection of OARs (rows r to y) are optimized, in the order of their priority. The priority value can be a user-defined priority.
[0124] The fourth column of Table 1 gives the name of the structure (i.e., anatomical region) to which the constraint or target refers. Thus, the structure name represents the anatomical structure. The structure is obtained by a process called segmentation, in which contours are drawn on slices of an MRI image or CT image to identify different structures. The contours can be generated manually (e.g., by a physician, dosimetrist, or health worker) or automatically using atlas-based automatic segmentation software.
[0125] In Table 1, "Cost Function (parameter values)" relates to the type of cost function to be used. For some cost functions, additional parameters are provided. "Goal" refers to the goal to be achieved by the treatment planning system.
[0126] For example, in row m, the reference target is 97% of the urethral PRV (a) to achieve a dose of 33.2 Gy. The cost function associated with the reference target is the "target penalty".
[0127] For each structure, one or more cost functions and associated objectives are defined, each achieving a different purpose. For example, at rows r to t, for the "rectum" structure, different cost functions and objectives are applied.
[0128] In Table 1, the hierarchical order relates to overlapping structural volumes. When a structure includes overlapping voxels, the structure with a higher hierarchical order "owns" the voxel, e.g., the voxel is only included in the cost function associated with that structure. The voxel is not included in any cost function associated with a structure with a lower hierarchical order (i.e., a structure that does not "own" the voxel).
[0129] Further examples of wish lists are provided in Naccarato, S., Rigo, M., Pellegrini, R., Voet, P., Akhiat, H., Gurrera, D., De Simone, A., Sicignano, G., Mazzola, R., Figlia, V. and Ricchetti, F., 2022. Automated planning for prostate stereotactic body radiation therapy on the 1.5T MR-Linac. Advances in radiation oncology, 7(3), p.100865.
[0130] Figure 3A block diagram of an implementation of a radiation therapy system 300 is illustrated. The radiation therapy system 300 includes a computing system 310 within which a set of instructions for causing the computing system 310 to perform any one or more of the methods discussed herein may be executed. The computing system 310 may implement a treatment planning system. The computing system 310 may also be referred to as a computer. The treatment planning system 310 may perform any of the methods described herein. In particular, the methods described herein may be implemented by a processor 311 of the treatment planning system 310.
[0131] Computing system 310 should be considered to include any number of machines or machine collections, such as one or more computing devices, which individually or jointly execute one or more instruction sets to perform any one or more methods discussed herein. That is, hardware and / or software can be provided in a single computing device, or distributed on multiple computing devices in a computing system. In some implementations, one or more elements of a computing system can be connected (e.g., networked) to other machines in, for example, a local area network (LAN), an intranet, an extranet, or the Internet. One or more elements of a computing system can operate with the ability of a server or client machine in a client-server network environment, or operate as a peer machine in a peer-to-peer (or distributed) network environment. One or more elements of a computing system can be a personal computer (PC), a tablet computer, a set-top box (STB), a personal digital assistant (PDA), a cellular phone, a network appliance, a server, a network router, a switch or a bridge, or any machine capable of executing a set of instructions (sequential or otherwise), which specifies the action to be taken by the machine.
[0132] The computing system 310 includes a controller circuit 311 and a memory 313 (e.g., a read-only memory (ROM), a flash memory, a dynamic random access memory (DRAM) such as a synchronous DRAM (SDRAM) or a Rambus DRAM (RDRAM), etc.). The memory 313 may include a static memory (e.g., a flash memory, a static random access memory (SRAM), etc.) and / or an auxiliary memory (e.g., a data storage device), which communicate with each other via a bus (not shown).
[0133] Controller circuit 311 represents one or more general-purpose processors, such as microprocessors, central processing units, accelerated processing units, etc. More particularly, controller circuit 311 may include complex instruction set computing (CISC) microprocessors, reduced instruction set computing (RISC) microprocessors, very long instruction words (VLIW) microprocessors, processors implementing other instruction sets, or processors implementing a combination of instruction sets. Controller circuit 311 may also include one or more special processing devices, such as application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs), digital signal processors (DSPs), network processors, etc. One or more processors of the controller circuit may have a multi-core design. Controller circuit 311 is configured to execute processing logic for executing the operations and steps discussed herein.
[0134] The computing system 310 may also include a network interface circuit 318. The computing system 310 may be communicatively coupled to an input device 320 and / or an output device 330 via an input / output circuit 317. In some implementations, the input device 320 and / or the output device 330 may be elements of the computing system 310. The input device 320 may include an alphanumeric input device (e.g., a keyboard or a touch screen), a cursor control device (e.g., a mouse or a touch screen), an audio device such as a microphone, and / or a tactile input device. The output device 330 may include an audio device such as a speaker, a video display unit (e.g., a liquid crystal display (LCD) or a cathode ray tube (CRT)), and / or a tactile output device. In some implementations, the input device 320 and the output device 330 may be provided as a single device or separate devices.
[0135] In some implementations, the computing system 310 may include an image processing circuit 319. The image processing circuit 319 may be configured to process image data 380 (e.g., images or imaging data), such as medical images obtained from one or more imaging data sources, the treatment device 350, and / or the image acquisition device 340. The image processing circuit 319 may be configured to process or pre-process the image data. For example, the image processing circuit 319 may convert the received image data into a specific format, size, resolution, etc. In some implementations, the image processing circuit 319 may be combined with the controller circuit 311.
[0136] In some implementations, the radiation therapy system 300 may also include an image acquisition device 340 and / or a treatment device 350, such as described herein. Figure 5The device disclosed in the example of . Image acquisition device 340 and treatment device 350 can be provided as a single device. In some implementations, treatment device 350 is configured to perform imaging, for example in addition to providing treatment and / or during treatment. Treatment device 350 includes the main radiation delivery components of the radiation treatment system, such as beam shaping device 550.
[0137] The image acquisition device 340 may be configured to perform positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), single positron emission computed tomography (SPECT), X-ray, and the like.
[0138] Image acquisition device 340 may be configured to output image data 380 that may be accessed by computing system 310. Treatment device 350 may be configured to output treatment data 360 that may be accessed by computing system 310.
[0139] The computing system 310 may be configured to access or obtain treatment data 360, planning data 370, and / or image data 380. The treatment data 360 may be obtained from an internal data source (e.g., from the memory 313) or from an external data source (e.g., the treatment device 350 or an external database). The planning data 370 may be obtained from the memory 313 and / or from an external source such as a planning database. The planning data 370 may include information obtained from one or more of the image acquisition device 340 and the treatment device 350.
[0140] Figure 4 4 is a schematic diagram illustrating a computer program product 400 according to some embodiments. The various methods described above may be implemented by a computer program. The computer program may include computer code (eg, instructions) 410, which is arranged to instruct a computer to execute a computer program. Figure 2 Method 200 is described.
[0141] For example, about Figure 2 The steps of the method described above may be performed by computer code 410. The steps of the method described above may be performed in any suitable order. Figure 4The computer program and / or code 410 for performing this method is provided to a device such as a computer on one or more computer readable media described in or more generally on a computer program product 400. The computer readable medium may be transient or non-transient. The one or more computer readable media 400 may be, for example, an electronic, magnetic, optical, electromagnetic, infrared or semiconductor system, or a propagation medium for data transmission (e.g., for downloading code via the Internet). Alternatively, the one or more computer readable media may take the form of one or more physical computer readable media, such as semiconductor or solid-state memory, magnetic tape, removable computer disk, random access memory (RAM), read-only memory (ROM), hard disk and optical disk (e.g., CD-ROM, CD-R / W or DVD). The instructions 410 may also reside completely or at least partially in the memory 313 and / or in the controller circuit 311 during its execution by the computer system 310, the memory 313 and the controller circuit 311 also constituting computer readable storage media.
[0142] In implementation, the modules, components, and other features described herein may be implemented as discrete components, or integrated into the functionality of hardware components such as ASICs, FPGAs, DSPs, or similar devices.
[0143] A "hardware component" is a tangible (e.g., non-transient) physical component (e.g., a set of one or more processors) that is capable of performing certain operations and may be configured or arranged in some physical manner. A hardware component may include dedicated circuitry or logic that is permanently configured to perform certain operations. A hardware component may include a dedicated processor, such as an FPGA or ASIC. A hardware component may also include programmable logic or circuitry that is temporarily configured by software to perform certain operations.
[0144] In addition, modules and components can be implemented as firmware or functional circuits within hardware devices. Further, modules and components can be implemented in any combination of hardware devices and software components, or only in software (e.g., code stored or otherwise embodied in a machine-readable medium or transmission medium).
[0145] Figure 5 A radiotherapy apparatus according to the invention is described. Figure 5 A cross section of a radiotherapy apparatus 500 is shown including a radiation head 504 and a beam receiving device 506, both of which are attached to a gantry 502. The radiation head 504 includes a radiation source 507 that emits a radiation beam 522. The radiation head 504 also includes a beam shaping device 550 that controls the size and shape of the radiation field associated with the beam.
[0146] The beam receiving device 506 is configured to receive radiation emitted from the radiation head 504 in order to absorb and / or measure the radiation beam. Figure 5 In the view shown, the radiation head 504 and the beam receiving device 506 are positioned diametrically opposite each other.
[0147] The gantry 502 is rotatable and supports the radiation head 504 and the beam receiving device 506 so that they can rotate about an axis of rotation 505, which can coincide with the longitudinal axis of the patient. Figure 5 As shown, the gantry provides rotation of the radiation head 504 and the beam receiving device 506 in a plane perpendicular to the longitudinal axis of the patient (e.g., the sagittal plane). Three gantry directions XG, YG, and ZG can be defined, wherein the YG direction is perpendicular to the gantry rotation axis. The ZG direction extends from a point on the gantry corresponding to the radiation head toward the gantry rotation axis. Therefore, from the patient reference system, the ZG direction rotates as the gantry rotates.
[0148] Figure 5 Also shown is a support surface 510 on which a subject (or patient) is supported during radiation therapy. The radiation head 504 is configured to rotate about a rotation axis 505 so that the radiation head 504 directs radiation to the subject from various angles around the subject so as to spread the radiation dose received by healthy tissue to a larger area of healthy tissue while accumulating a prescribed radiation dose at the target area.
[0149] The radiation therapy apparatus 500 is configured to deliver a radiation beam towards a radiation isocenter that is approximately located on a rotation axis 505 at the center of the gantry 502 , regardless of the angle at which the radiation head 504 is placed.
[0150] The rotatable gantry 502 and radiation head 504 are sized to allow for a central aperture 580. Central aperture 580 provides an opening sufficient to allow a subject to be positioned therethrough without being accidentally contacted by the radiation head 504 or other mechanical components as the gantry rotates the radiation head 504 about the subject.
[0151] like Figure 5 As shown, the radiation head 504 emits a radiation beam 522 along a beam axis 590 (or radiation axis or beam path), wherein the beam axis 590 is used to define the direction in which the radiation head emits radiation. The radiation beam 522 is incident on a beam receiving device 506, which may include at least one of a beam stopper and a radiation detector. The beam receiving device 506 is attached to the gantry 502 on a side diametrically opposite to the radiation head 504 to attenuate and / or detect the radiation beam after the beam passes through the subject.
[0152] For example, radiation beam axis 590 may be defined as the center or point of maximum intensity of radiation beam 522 .
[0153] The beam shaper 550 defines the spread of the radiation beam 522. The beam shaper 550 is configured to adjust the shape and / or size of the radiation field generated by the radiation source. The beam shaper 550 achieves this by defining a variable shaped aperture (also referred to as a window or opening) to calibrate the radiation beam 522 to a selected cross-sectional shape. In this example, the beam shaper 550 may be provided by a combination of an aperture and a multi-leaf collimator (MLC). The beam shaper 550 may also be referred to as a beam modifier.
[0154] The radiation therapy device 500 can be configured to perform radiation therapy in coplanar and non-coplanar (also called tilted) modes. In coplanar therapy, radiation is emitted in a plane that is perpendicular to the axis of rotation of the radiation head 504. In non-coplanar therapy, radiation is emitted at an angle that is not perpendicular to the axis of rotation. To perform coplanar and non-coplanar therapy, the radiation head 504 can be moved between at least two positions, one in which radiation is emitted in a plane that is perpendicular to the axis of rotation (coplanar configuration) and one in which radiation is emitted in a plane that is not perpendicular to the axis of rotation (non-coplanar configuration).
[0155] In a coplanar configuration, the radiation head is positioned to rotate about an axis of rotation and in a first plane. In a non-coplanar configuration, the radiation head is tilted relative to the first plane so that the radiation field generated by the radiation head is directed at an oblique angle relative to the first plane and the axis of rotation. In a non-coplanar configuration, the radiation head is positioned to rotate in a respective second plane parallel to and displaced from the first plane. The radiation beam is emitted at an oblique angle relative to the second plane so that the beam sweeps out a cone when the radiation head rotates.
[0156] When the radiotherapy apparatus is in coplanar mode and non-coplanar mode, the beam receiving device 506 remains in the same position relative to the rotatable gantry. Therefore, the beam receiving device 506 is configured to rotate about the rotation axis in the same plane in both coplanar mode and non-coplanar mode. This can be the same plane as the plane in which the radiation head rotates.
[0157] The beam shaping device 550 is configured to reduce the spread of the radiation field in a non-coplanar configuration compared to a coplanar configuration.
[0158] Radiation therapy apparatus 500 includes a controller 540 programmed to control radiation source 507, beam receiving device 506, and gantry 502. Controller 540 may perform functions or operations such as treatment planning, treatment delivery, image acquisition, image processing, motion tracking, motion management, and / or other tasks involved in a radiation therapy procedure.
[0159] The controller 540 is programmed to control features of the apparatus 500 in accordance with a radiation therapy plan in order to irradiate a target area of the patient, also referred to as target tissue. The treatment plan includes information about a specific dose to be applied to the target tissue as well as other parameters such as beam angles, dose histogram volume information, the number of radiation beams to be used during treatment, the dose of each beam, etc. The controller 540 is programmed to control various components of the apparatus 500, such as the gantry 502, the radiation head 504, the beam receiving device 506, and the support surface 510, in accordance with the treatment plan.
[0160] The hardware components of the controller 540 may include one or more computers (e.g., general-purpose computers, workstations, servers, terminals, portable / mobile devices, etc.); processors (e.g., central processing units (CPUs), graphics processing units (GPUs), microprocessors, digital signal processors (DSPs), field programmable gate arrays (FPGAs), dedicated or specially designed processors, etc.); memory / storage devices, such as memory (e.g., read-only memory (ROM), random access memory (RAM), flash memory, hard disk drives, optical disks, solid-state drives (SSDs), etc.); input devices (e.g., keyboards, mice, touch screens, MICS, buttons, knobs, trackballs, joysticks, handles, joysticks, etc.); output devices (e.g., displays, printers, speakers, vibration devices, etc.); circuits; printed circuit boards (PCBs); or other suitable hardware. The software components of the controller 140 may include operating device software, application software, etc.
[0161] The radiation head 504 may be connected to a head actuator 530 that is configured to actuate the radiation head 504, for example, between a coplanar configuration and one or more non-coplanar configurations. This may involve translation and rotation of the radiation head 504 relative to the gantry. In some implementations, the head actuator may include a curved track along which the radiation head 504 may move to adjust the position and angle of the radiation head 504. The controller 540 may control the configuration of the radiation head 504 via the head actuator 530.
[0162] The beam shaping device 550 includes a shaping actuator 532. The shaping actuator is configured to control the position of one or more elements in the beam shaping device 550 so as to shape the radiation beam 522. In some implementations, the beam shaping device 550 includes an MLC, and the shaping actuator 532 includes a means for actuating leaves of the MLC. The beam shaping device 550 may also include an aperture, and the shaping actuator 532 may include a means for actuating a block of the aperture. The controller 540 may control the beam shaping device 550 via the shaping actuator 532.
[0163] The treatment plan may include positioning information of the beam shaping device 550. The positioning information of the beam shaping device 550 may include information indicating the configuration of one or more elements of the beam shaping device 550, such as the configuration of leaves of the MLC of the beam shaping device 550, the configuration of the diaphragm of the beam shaping device 550, the configuration of an opening (e.g., a window or aperture) of the MLC, etc.
[0164] As described herein, the goal of the optimizer (or optimization process) is to find an optimized parameter set that minimizes the cost function. However, it will be understood that alternatively and equivalently, the goal of the optimizer (or optimization process) can be to find an optimized parameter set that maximizes the reward function.
[0165] Unless specifically stated otherwise, as will be apparent from the following discussion, it should be understood that throughout the specification, discussions utilizing terms such as "receiving," "determining," "comparing," "implementing," "maintaining," "identifying," "obtaining," "accessing," etc. refer to the actions and processes of a computer system or similar electronic computing device that manipulates data represented as physical (electronic) quantities within the computer system's registers and memories and transforms it into other data similarly represented as physical quantities within the computer system memories or registers or other such information storage, transmission, or display devices.
[0166] Although certain embodiments have been described, these embodiments are presented by way of example only and are not intended to limit the scope of the appended claims. In fact, the novel methods and devices described herein may be embodied in a variety of other forms; in addition, various omissions, substitutions, and changes in the form of the methods and devices described herein may be made.
[0167] The following numbered statements set forth embodiments of the invention:
[0168] 1. A computer-implemented method for radiation therapy planning, the method comprising:
[0169] receiving a reference dose value, wherein the reference dose value is a maximum radiation dose defined in a first region of a patient for radiation therapy;
[0170] applying an optimization process to a treatment plan for radiation therapy of a patient, wherein the optimization process seeks to minimize a cost function representing dose excesses above a reference dose value; and
[0171] In response to determining that the dosage overdose value is below the threshold value:
[0172] reducing the reference dose value; and
[0173] The optimization process is reapplied to the treatment planning, wherein the optimization process seeks to minimize the cost function based on the reduced reference dose value.
[0174] 2. The method according to embodiment 1 further comprises the steps of iteratively reducing the reference dose value and reapplying the optimization process until a stop criterion is reached.
[0175] 3. The method according to embodiment 2, wherein the stopping criterion includes the optimization process failing to reduce the cost function such that the dose excess value is below a threshold.
[0176] 4. The method according to embodiment 3, wherein the stopping criterion comprises that the optimization process cannot reduce the cost function after a defined number of optimization iterations or a defined amount of time such that the dose excess value is below a threshold value.
[0177] 5. The method according to any one of embodiments 2 to 4, further comprising outputting an optimized parameter set for the treatment plan in response to determining that the stopping criteria have been reached.
[0178] 6. The method of embodiment 5, wherein the set of optimized parameters defines a flux map for treatment planning.
[0179] 7. The method according to embodiment 5 or 6 further comprises determining a configuration of the radiation therapy system for treatment planning based on the optimized parameter set.
[0180] 8. The method of any of the preceding embodiments, wherein the optimization process iteratively adjusts the treatment plan to minimize a cost function.
[0181] 9. The method according to any of the preceding embodiments, wherein the reference dose value is reduced by a fixed value.
[0182] 10. The method according to embodiment 9, wherein the fixed value is between 0.3 Gy and 0.7 Gy.
[0183] 11. The method of any one of embodiments 1 to 8, wherein the reference dose value is reduced by an amount based on one or more of: the reference dose value, a threshold value, and a difference between the reference dose value and the threshold value.
[0184] 12. A method according to any of the preceding embodiments, wherein the dose excess value comprises a root mean square dose excess value.
[0185] 13. The method of any of the preceding embodiments, wherein the cost function is a quadratic overdose cost function.
[0186] 14. The method of embodiment 13, wherein the cost function is proportional to the following formula:
[0187]
[0188] It represents the sum over the i voxels in the volume V of the first region, where Vi is the volume of the ith voxel, D i is the dose delivered to the ith voxel, Δ is the reference dose value, and the operator [D i -Δ] + Indicates [D i -Δ] and the maximum value among zero.
[0189] 15. The method according to any one of the preceding embodiments, wherein the method further comprises:
[0190] Prior to applying the optimization process, a maximum dose excess value is received, wherein the threshold value is equal to or less than the maximum dose excess value.
[0191] 16. The method according to embodiment 15, wherein the reference targets of the optimization process include a reference dose value and a maximum dose excess.
[0192] 17. The method of any of the preceding embodiments, wherein the optimization process further seeks to minimize a cost function subject to one or more constraints.
[0193] 18. The method of any of the preceding embodiments, wherein the optimization process seeks to minimize a cost function with respect to one or more optimizable parameters.
[0194] 19. The method according to embodiment 18, wherein the one or more optimizable parameters include one or more of the following parameters: dose excess value, beamlet weight, beam angle, dose histogram volume information, number of radiation beams and dose per beam.
[0195] 20. The method according to any of the preceding embodiments, wherein the first region comprises a target region and / or an organ at risk (OAR) for radiotherapy.
[0196] 21. A data processing device, comprising:
[0197] a memory storing computer executable instructions; and
[0198] A processor configured to execute instructions to perform the method according to any one of embodiments 1 to 20.
[0199] 22. A computer program comprising instructions which, when executed by a computer, cause the computer to perform the method according to any one of embodiments 1 to 20.
[0200] 23. A non-transitory computer-readable storage medium comprising instructions which, when executed by a computer, cause the computer to perform the method according to any one of embodiments 1 to 20.
Claims
1. A computer-implemented method for radiation therapy planning, the method comprising: receiving a reference dose value, wherein the reference dose value is a maximum radiation dose defined in a first region of a patient for radiation therapy; applying an optimization process to a treatment plan for radiation therapy of the patient, wherein the optimization process reduces a cost function representing dose excess values above the reference dose value; and In response to determining that the dosage overdose value is below a threshold value: reducing the reference dose value; and The optimization process is reapplied to the treatment plan, wherein the optimization process further reduces the cost function based on the reduced reference dose value.
2. The method according to claim 1, characterized in that Also includes: The steps of iteratively lowering the reference dose value and reapplying the optimization process are performed until a stopping criterion is reached.
3. The method according to claim 2, characterized in that The stopping criterion includes the inability of the optimization process to reduce the cost function such that the dose excess value is below the threshold.
4. The method according to claim 2, characterized in that: The stopping criterion comprises that the optimization process cannot reduce the cost function such that the dose excess value is below the threshold value after a defined number of optimization iterations or a defined amount of time.
5. The method according to claim 2, characterized in that: Also includes: In response to determining that the stopping criteria have been met, an optimized set of parameters for the treatment plan is output.
6. The method according to claim 5, characterized in that The set of optimized parameters defines a flux map for the treatment plan.
7. The method according to claim 5, characterized in that Also includes: A configuration of the radiation therapy system for the treatment plan is determined based on the optimized set of parameters.
8. The method according to claim 1, characterized in that The optimization process iteratively adjusts the treatment plan to minimize the cost function.
9. The method according to claim 1, characterized in that: The reference dose value is decreased by a fixed value.
10. The method according to claim 9, characterized in that The fixed value is between 0.3 Gy and 0.7 Gy.
11. The method according to claim 1, characterized in that: The reference dose value is reduced by an amount based on one or more of: the reference dose value, the threshold value, and a difference between the reference dose value and the threshold value.
12. The method according to claim 1, characterized in that The dose excess value includes a root mean square dose excess value.
13. The method according to claim 1, characterized in that The cost function is a quadratic overdose cost function.
14. The method according to claim 1, characterized in that The cost function is proportional to: This formula represents the sum over the i voxels in the volume V of the first region, where V i is the volume of the ith voxel, D i is the dose delivered to the i-th voxel, Δ is the reference dose value, and the operator [D i -Δ] + Indicates [D i -Δ] and the maximum value among zero.
15. The method according to claim 1, characterized in that The method further comprises: Prior to applying the optimization process, a maximum dose excess value is received, wherein the threshold value is equal to or less than the maximum dose excess value.
16. The method according to claim 15, characterized in that The reference targets of the optimization process include the reference dose value and the maximum dose excess.
17. The method according to claim 1, characterized in that The optimization process also reduces the cost function subject to one or more constraints.
18. The method according to claim 1, characterized in that The optimization process also reduces the cost function with respect to one or more optimizable parameters.
19. The method according to claim 18, characterized in that The one or more optimizable parameters include one or more of the following parameters: the dose excess value, one or more beamlet weights, one or more beam angles, dose histogram volume information, the number of radiation beams, and the dose per beam.
20. The method according to claim 1, characterized in that The first region includes a target region and / or an organ at risk (OAR) for the radiation therapy.
21. A data processing device, comprising: a memory storing computer executable instructions; as well as A processor configured to execute the instructions to: receiving a reference dose value, wherein the reference dose value is a maximum radiation dose defined in a first region of a patient for radiation therapy; applying an optimization process to a treatment plan for radiation therapy of the patient, wherein the optimization process reduces a cost function representing dose excess values above the reference dose value; and In response to determining that the dosage overdose value is below a threshold value: reducing the reference dose value; and The optimization process is reapplied to the treatment plan, wherein the optimization process further reduces the cost function based on the reduced reference dose value.
22. A non-transitory computer-readable storage medium comprising instructions which, when executed by a computer, cause the computer to: Receive a reference dose value, where The reference dose value is a maximum radiation dose defined in a first region of the patient for radiation therapy; applying an optimization process to a treatment plan for radiation therapy of the patient, wherein the optimization process reduces a cost function representing dose excess values above the reference dose value; and In response to determining that the dosage overdose value is below a threshold value: reducing the reference dose value; and The optimization process is reapplied to the treatment plan, wherein the optimization process further reduces the cost function based on the reduced reference dose value.
